Our findings align with those of Justicia et al. 2006, who found that blocking VCAM-1 in an ischaemic mouse model alters the composition of the infiltrating leukocytes (by reducing monocyte infiltration and increasing neutrophils and lymphocytes), which might not necessarily be beneficial for the outcome of stroke. Here, VCAM1 is linked to Stroke.